DocGo Files 8-K on Operations & Financial Condition
Ticker: DCGO · Form: 8-K · Filed: Jan 10, 2024 · CIK: 1822359
| Field | Detail |
|---|---|
| Company | Docgo INC. (DCGO) |
| Form Type | 8-K |
| Filed Date | Jan 10, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: corporate-update, regulation-fd, financial-condition
TL;DR
**DocGo just filed an 8-K updating on operations and financials, keep an eye out for more details.**
AI Summary
DocGo Inc. filed an 8-K on January 10, 2024, to report on its current operations and financial condition, specifically under Item 2.02 and Item 7.01. This filing indicates that the company is providing an update on its business, which is important for investors as it signals transparency and could precede more detailed financial disclosures. For shareholders, this matters because it's an official communication about the company's health and future prospects, potentially influencing stock performance.
Why It Matters
This filing signals DocGo is providing an update on its business, which can impact investor confidence and stock valuation. It's a formal disclosure that could precede significant news.
Risk Assessment
Risk Level: low — This 8-K is a routine disclosure of current operations and financial condition, not indicating any immediate negative events.
Analyst Insight
A smart investor would monitor DocGo Inc. for subsequent filings or press releases that provide specific details about the 'Results of Operations and Financial Condition' mentioned in this 8-K, as this filing itself is a placeholder for more substantive news.
Key Players & Entities
- DocGo Inc. (company) — the registrant filing the 8-K
- January 10, 2024 (date) — date of earliest event reported and filing date
- 001-39618 (other) — Commission File Number for DocGo Inc.
- DCGO (other) — trading symbol for DocGo Inc. common stock
- The Nasdaq Stock Market LLC (other) — exchange where DocGo Inc. common stock is registered
FAQ
What is the primary purpose of DocGo Inc.'s 8-K filing on January 10, 2024?
The primary purpose of DocGo Inc.'s 8-K filing on January 10, 2024, is to report on 'Results of Operations and Financial Condition' under Item 2.02 and 'Regulation FD Disclosure' under Item 7.01, as indicated in the 'ITEM INFORMATION' section of the filing.
What is DocGo Inc.'s trading symbol and on which exchange is its common stock registered?
DocGo Inc.'s trading symbol is 'DCGO', and its common stock, with a par value of $0.0001 per share, is registered on 'The Nasdaq Stock Market LLC', as stated under 'Securities registered pursuant to Section 12(b) of the Act'.
What is the address of DocGo Inc.'s principal executive offices?
The address of DocGo Inc.'s principal executive offices is '35 West 35th Street, Floor 6, New York, New York 10001', as listed in the filing.
What is DocGo Inc.'s Commission File Number and IRS Employer Identification Number?
DocGo Inc.'s Commission File Number is '001-39618' and its I.R.S. Employer Identification No. is '85-2515483', according to the filing's cover page.
What was DocGo Inc.'s former company name and when did the name change occur?
DocGo Inc.'s former company name was 'Motion Acquisition Corp.', and the date of the name change was '20200824', as detailed in the 'FORMER COMPANY' section of the filing.
Filing Stats: 570 words · 2 min read · ~2 pages · Grade level 10 · Accepted 2024-01-10 16:24:23
Key Financial Figures
- $0.0001 — ch registered Common stock, par value $0.0001 per share DCGO The Nasdaq Stock Market
Filing Documents
- dcgo-20240110.htm (8-K) — 31KB
- exhibit991.htm (EX-99.1) — 15KB
- 0001822359-24-000005.txt ( ) — 178KB
- dcgo-20240110.xsd (EX-101.SCH) — 2KB
- dcgo-20240110_lab.xml (EX-101.LAB) — 24KB
- dcgo-20240110_pre.xml (EX-101.PRE) — 13KB
- dcgo-20240110_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On January 10, 2024, DocGo Inc. (the "Company") issued a press release announcing, among other things, select preliminary financial results for fiscal year 2023 and select preliminary guidance for fiscal year 2024 (the "Press Release"). The Press Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K (this "Current Report"). The Press Release also responds to a report issued by Fuzzy Panda Research, a short seller, on January 9, 2024.
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. The information set forth in Item 2.02 of this Current Report is incorporated into this Item 7.01 by reference. The information in Item 2.02 and this Item 7.01 of this Current Report, including Exhibit 99.1, is being furnished, and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated January 10, 202 4. 104 Cover Page Interactive Data File (formatted as Inline XBRL). 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DOCGO INC. By: /s/ Norman Rosenberg Name: Norman Rosenberg Title: Chief Financial Officer and Treasurer Date: January 10, 2024 2